Biotech Law 
Novartis calls students to participate in BioCamp at Hyderabad from July 30 – pharmabiz.com
BioCamp is open to postgraduate students and young researchers in natural sciences, medicine, biotechnology, bio-informatics, pharmacy, business administration or law (specialization in Intellectual Property Rights) interested in pursuing a career in the …
United States: Manufacturers Must Soon Track And Report Payments To Health Care Professionals: Are You Prepared? – Mondaq
The Patient Protection and Affordable Care Act of 2009 (“Health Reform Law”) contains many provisions aimed at reducing health care fraud and abuse in the United States. One provision aims to ensure transparency in the relationships between manufacturers …
Bar exam passage rate almost unchanged at 42% for February test – The Business Journal
Click here for February 2012 bar exam results for the State Bar. Kathy Robertson covers health care, labor/workplace issues, law, immigration, medical technology and biotechnology for the Sacramento Business Journal.
Virginia business briefs for May 22 – Richmond Times-Dispatch
international and intellectual property law. Gallagher counseled advanced technology and biotech startups as well as managing the firm’s China practice, supervising lawyers and paralegals in Richmond and Guangzhou. Gallagher is a co-founder and …
Nigeria: ‘Unsafe Seeds Will Not Be Commercialized’ – AllAfrica.com
Professor Solomon said that the agency would not condone breach of the upcoming biosafety law. He said that there were cases of death from people taking fruits or cassava, because they were not tested and assured that biotechnology induced crops … Continue reading
Virginia Bio Names Jeffrey M. Gallagher Interim Executive Director – Phramalive.com
international and intellectual property law. Mr. Gallagher counseled advanced technology and biotech start-ups as well as managing the firm’s China practice, supervising lawyers and paralegals in Richmond and Guangzhou. “Virginia Bio is fortunate to have …
600 Patients Recruited in Active Biotech’s and Ipsen’s tasquinimod Clinical Phase III Study – msnbc.com
unless so required by applicable law. The Group’s business is subject to the risk factors outlined in its registration documents filed with the French Autorité des Marchés Financiers. Active Biotech is obligated to publish the information …
600 Patients Recruited in Active Biotech’s and Ipsen’s tasquinimod Clinical Phase III Study – Market Wire
unless so required by applicable law. The Group’s business is subject to the risk factors outlined in its registration documents filed with the French Autorité des Marchés Financiers. Active Biotech is obligated to publish the information contained in …
Active Biotech AB : 600 Patients Recruited in Active Biotech’s and Ipsen’s tasquinimod Clinical Phase III Study – 4-traders (press release)
Active Biotech AB (NASDAQ OMX NORDIC … unless so required by applicable law. The Group’s business is subject to the risk factors outlined in its registration documents filed with the French Autorité des Marchés Financiers. E-mail …
FDA Issues Guidance On Biotech Pharmaceutical Testing – site.law360.com
Law360, New York (May 18, 2012, 5:15 PM ET) — The U.S. Food and Drug Administration on Thursday released new guidance for early-stage testing of biotech drugs, clarifying and revising advice intended to avert serious side effects and minimize animal … Continue reading
